As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

Most adults in the United States with physical chronic health conditions manage them at work but have not told their employer ...

The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...

Virtual reality headsets for visual field testing in glaucoma offer a variety of benefits for the patient, the practice and ...

The American Heart Association and American College of Cardiology issued a scientific statement detailing clinical guidance ...

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

Women caregivers are more likely to report emotional stress, struggles with work-life balance and depression or anxiety ...

The latest data from The Vision Council’s Market inSights report indicate that the proportion of contact lenses and glasses ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

With a new clinical practice guideline, primary care providers can offer the best stroke rehabilitation care possible to ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...